ZUMA-7 trial shows the value of axicabtagene ciloleucel for early relapsed B-cell lymphoma

Nierengarten, MB

CANCER, 2023; 129 (19): 2926

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索